EP2364145A4 - Dosierformen für die schnelle und anhaltende anhebung des ph-wertes im magen - Google Patents

Dosierformen für die schnelle und anhaltende anhebung des ph-wertes im magen

Info

Publication number
EP2364145A4
EP2364145A4 EP09755268.1A EP09755268A EP2364145A4 EP 2364145 A4 EP2364145 A4 EP 2364145A4 EP 09755268 A EP09755268 A EP 09755268A EP 2364145 A4 EP2364145 A4 EP 2364145A4
Authority
EP
European Patent Office
Prior art keywords
gastric
rapid
dosage forms
sustained elevation
sustained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09755268.1A
Other languages
English (en)
French (fr)
Other versions
EP2364145A1 (de
Inventor
John R Plachetka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pozen Inc
Original Assignee
Pozen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pozen Inc filed Critical Pozen Inc
Publication of EP2364145A1 publication Critical patent/EP2364145A1/de
Publication of EP2364145A4 publication Critical patent/EP2364145A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP09755268.1A 2008-05-30 2009-05-29 Dosierformen für die schnelle und anhaltende anhebung des ph-wertes im magen Withdrawn EP2364145A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12902908P 2008-05-30 2008-05-30
PCT/US2009/003281 WO2009145905A1 (en) 2008-05-30 2009-05-29 Dosage forms for the rapid and sustained elevation of gastric ph

Publications (2)

Publication Number Publication Date
EP2364145A1 EP2364145A1 (de) 2011-09-14
EP2364145A4 true EP2364145A4 (de) 2013-11-13

Family

ID=41377439

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09755268.1A Withdrawn EP2364145A4 (de) 2008-05-30 2009-05-29 Dosierformen für die schnelle und anhaltende anhebung des ph-wertes im magen

Country Status (3)

Country Link
EP (1) EP2364145A4 (de)
CA (1) CA2740974A1 (de)
WO (1) WO2009145905A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US9265732B2 (en) 2006-03-06 2016-02-23 Pozen Inc. Dosage forms for administering combinations of drugs
EA201100313A1 (ru) 2008-09-09 2011-10-31 Астразенека Аб Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом
CA2764963C (en) 2009-06-25 2016-11-01 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
WO2013101897A2 (en) 2011-12-28 2013-07-04 Pozen Inc. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1559612A (zh) * 2004-02-18 2005-01-05 孔庆忠 一种治疗消化系统溃疡药物组合物
US20070031497A1 (en) * 2002-10-16 2007-02-08 Orexo Ab Gastric acid secretion inhibiting composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0101379D0 (sv) * 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
US20070243251A1 (en) * 2002-12-20 2007-10-18 Rajneesh Taneja Dosage Forms Containing A PPI, NSAID, and Buffer
US20060165797A1 (en) * 2005-01-12 2006-07-27 Pozen Inc. Dosage form for treating gastrointestinal disorders
EP2086543A2 (de) * 2006-10-27 2009-08-12 The Curators of the University of Missouri Zusammensetzungen mit mindestens einem säurelabilen protonenpumpen-hemmenden mittel, wahlweise anderen pharmazeutisch wirksamen mitteln und anwendungsverfahren dafür

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070031497A1 (en) * 2002-10-16 2007-02-08 Orexo Ab Gastric acid secretion inhibiting composition
CN1559612A (zh) * 2004-02-18 2005-01-05 孔庆忠 一种治疗消化系统溃疡药物组合物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2009145905A1 *

Also Published As

Publication number Publication date
EP2364145A1 (de) 2011-09-14
CA2740974A1 (en) 2009-12-03
WO2009145905A1 (en) 2009-12-03

Similar Documents

Publication Publication Date Title
AP2860A (en) Carbazole compounds and therapeutic uses of the compounds
HRP20171421T1 (hr) Kruti oblici doziranja bendamustina
ZA200906946B (en) Inhibitors of iap
EP1978876A4 (de) Vorrichtungen und verfahren zur gastrointestinalen anregung
IL211042A0 (en) Imidazopyridin-2-one derivatives and uses thereof
EP2068864A4 (de) Therapeutische verwendungen von urolithinen
ZA201103635B (en) Azaquinolinone derivatives and uses thereof
EP2300011A4 (de) Therapeutische verfahren und verbindungen
EP2387572A4 (de) Proteinkinase-c-hemmer und ihre verwendung
IL201008A0 (en) Modified release dosage forms of tacrolimus
EP2324503A4 (de) Speichervorrichtungen und herstellungsverfahren dafür
IL211945A0 (en) Dosage forms that facilitate rapid activation of zymogen
GB0807018D0 (en) Antibodies and treatment
GB0900333D0 (en) Imidazolidine compounds and uses thereof
GB201211237D0 (en) CDK5 inhibitors and therapeutic uses thereof
EP2364145A4 (de) Dosierformen für die schnelle und anhaltende anhebung des ph-wertes im magen
PL2100692T5 (pl) Sposób wytwarzania urządzenia obróbkowego z korpusem z betonu
IL208611A0 (en) Device and process for the formation of microdepositions
GB2461976B (en) Detonation devices and methods
ZA201000802B (en) Process for the preparation of alfuzosin hydrochloride
HK1131039A1 (en) Pharmaceutical use of sophoricoside
PL2896614T3 (pl) Sposoby i związki do wytwarzania normorfinanów
EP2385840A4 (de) Materialien und verfahren zur behandlung von bluthochdruck
IL206951A0 (en) 3-alkyl-piperazine derivatives and uses thereof
EP2274294A4 (de) 5-demethoxyfumagillol und derivate davon

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110405

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1155655

Country of ref document: HK

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/20 20060101AFI20131003BHEP

Ipc: A61K 31/4439 20060101ALI20131003BHEP

Ipc: A61K 45/06 20060101ALI20131003BHEP

Ipc: A61K 9/24 20060101ALI20131003BHEP

Ipc: A61K 9/46 20060101ALI20131003BHEP

Ipc: A61K 31/4164 20060101ALI20131003BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20131011

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140509

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1155655

Country of ref document: HK